English

OCULAR THERAPEUTIX, INC.

EDGAR

OCUL Current report (8-K) · filed 2026-10-16

Annual consolidated revenue for 2025: about Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 51.95M, using the latest reported figures. The previous period, 2024, was about Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 63.72M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

13.5 million Unit_Standard_USD_9tVD0DxmP02Ww-6FWoOfug

2026 Q2 · Unit_Standard_USD_9tVD0DxmP02Ww-6FWoOfug

Exact inputs and evidence

Revenue: 13475000 Unit_Standard_USD_9tVD0DxmP02Ww-6FWoOfug Source

Operating margin

-609.34%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -82109000 Unit_Standard_USD_9tVD0DxmP02Ww-6FWoOfug Source
Revenue: 13475000 Unit_Standard_USD_9tVD0DxmP02Ww-6FWoOfug Source

Cash and cash equivalents: 599 million Unit_Standard_USD_9tVD0DxmP02Ww-6FWoOfug 2026-06-30 Source
Exact value

598641000 Unit_Standard_USD_9tVD0DxmP02Ww-6FWoOfug
Long-term debt including current maturities: 18 million Unit12 2017-09-30 Source
Exact value

18000000 Unit12
Shares outstanding: 220 million Unit_Standard_shares_m3CJmJG6yEKTrhoV_xk6kQ 2026-06-30 Source
Exact value

219589303 Unit_Standard_shares_m3CJmJG6yEKTrhoV_xk6kQ

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-16.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2025-12-31
Operating income: 3 of 11 periods available· newest 2025-12-31
Net income: 3 of 11 periods available· newest 2025-12-31
Operating cash flow: 3 of 11 periods available· newest 2025-12-31
Capital expenditure: 3 of 11 periods available· newest 2025-12-31
Total assets: Multiple units; comparison withheld· newest 2025-12-31
Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
Current assets: Multiple units; comparison withheld· newest 2025-12-31
Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-18.5%

Prior period

Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 63.72 million

2024-01-01 – 2024-12-31
Current period

Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 51.95 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

51951000 − 63723000 = -11772000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A

63723000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
51951000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · OCULAR THERAPEUTIX, INC. · 2025-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Year-over-year change in Revenue: -11772000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 51951000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2219252 Filing: 000110465926010664 Input fundies:Revenue: 63723000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2220276 Filing: 000110465926010664
The citation records this snapshot. The page link may show a newer release later.
Net income
−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 72.43 million

Prior period

−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 193.51 million

2024-01-01 – 2024-12-31
Current period

−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 265.94 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-265939000 − -193506000 = -72433000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A

-193506000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-265939000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · OCULAR THERAPEUTIX, INC. · 2025-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Year-over-year change in Net income: -72433000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -265939000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#3457075 Filing: 000110465926010664 Input fundies:NetIncome: -193506000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#3457992 Filing: 000110465926010664
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 70.21 million

Prior period

−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 134.68 million

2024-01-01 – 2024-12-31
Current period

−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 204.88 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-204883000 − -134677000 = -70206000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A

-134677000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-204883000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · OCULAR THERAPEUTIX, INC. · 2025-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Year-over-year change in Operating cash flow: -70206000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -204883000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2487263 Filing: 000110465926010664 Input fundies:OperatingCashFlow: -134677000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2488384 Filing: 000110465926010664
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+832.5%

Prior period

Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 1.29 million

2024-01-01 – 2024-12-31
Current period

Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 12.01 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

12010000 − 1288000 = 10722000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A

1288000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
12010000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · OCULAR THERAPEUTIX, INC. · 2025-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Year-over-year change in Capital expenditure: 10722000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 12010000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2493146 Filing: 000110465926010664 Input fundies:CapitalExpenditure: 1288000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2494225 Filing: 000110465926010664
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 51.95 million 100% of revenue
Operating costs Derived Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 321.97 million 620% of revenue
Operating income −Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 270.02 million −520% of revenue
Tax, interest and other Derived −Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 4.08 million −7.8% of revenue
Net income −Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 265.94 million −512% of revenue

Cash

Operating cash flow −Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 204.88 million −394% of revenue
Capital expenditure Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 12.01 million 23% of revenue
Free cash flow Derived −Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 216.89 million −417% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2023 Operating loss: operating costs were 241% of revenue.
2024 Operating loss: operating costs were 370% of revenue.
2025 Operating loss: operating costs were 620% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2023 2023-01-01 – 2023-12-31	58443000	140825000 Derived	-82382000	-1646000 Derived	-80736000	-76321000 Derived	Source 2023-01-01 – 2023-12-31: 58443000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Revenue Open source 2023-01-01 – 2023-12-31: -82382000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -80736000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Net Income Open source 2023-01-01 – 2023-12-31: -70234000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 6087000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	63723000	235504000 Derived	-171781000	21725000 Derived	-193506000	-135965000 Derived	Source 2024-01-01 – 2024-12-31: 63723000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Revenue Open source 2024-01-01 – 2024-12-31: -171781000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -193506000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Net Income Open source 2024-01-01 – 2024-12-31: -134677000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 1288000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	51951000	321968000 Derived	-270017000	-4078000 Derived	-265939000	-216893000 Derived	Source 2025-01-01 – 2025-12-31: 51951000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Revenue Open source 2025-01-01 – 2025-12-31: -270017000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -265939000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Net Income Open source 2025-01-01 – 2025-12-31: -204883000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 12010000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Capital Expenditure Open source

Amounts are exact, in Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 52M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A)	Source evidence
20232023-12-31	Revenue	58443000	Revenue: 58443000 Open source
20242024-12-31	Revenue	63723000	Revenue: 63723000 Open source
20252025-12-31	Revenue	51951000	Revenue: 51951000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-18.5% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20232023-12-31	Year over year	No prior comparable period	Revenue: 58443000 Open source
20242024-12-31	Year over year	9%	Revenue: 63723000 Open source Revenue: 58443000 Open source
20252025-12-31	Year over year	-18.5%	Revenue: 51951000 Open source Revenue: 63723000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -519.8% 2025

Net margin -511.9% 2025

Free cash flow margin -417.5% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20232023-12-31	Operating margin	-141%	Operating Income: -82382000 Open source Revenue: 58443000 Open source
20242024-12-31	Operating margin	-269.6%	Operating Income: -171781000 Open source Revenue: 63723000 Open source
20252025-12-31	Operating margin	-519.8%	Operating Income: -270017000 Open source Revenue: 51951000 Open source
20232023-12-31	Net margin	-138.1%	Net Income: -80736000 Open source Revenue: 58443000 Open source
20242024-12-31	Net margin	-303.7%	Net Income: -193506000 Open source Revenue: 63723000 Open source
20252025-12-31	Net margin	-511.9%	Net Income: -265939000 Open source Revenue: 51951000 Open source
20232023-12-31	Free cash flow margin	-130.6%	Revenue: 58443000 Open source Operating Cash Flow: -70234000 Open source Capital Expenditure: 6087000 Open source
20242024-12-31	Free cash flow margin	-213.4%	Revenue: 63723000 Open source Operating Cash Flow: -134677000 Open source Capital Expenditure: 1288000 Open source
20252025-12-31	Free cash flow margin	-417.5%	Revenue: 51951000 Open source Operating Cash Flow: -204883000 Open source Capital Expenditure: 12010000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A -204.9M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A)	Source evidence
20232023-12-31	Operating cash flow	-70234000	Operating Cash Flow: -70234000 Open source
20242024-12-31	Operating cash flow	-134677000	Operating Cash Flow: -134677000 Open source
20252025-12-31	Operating cash flow	-204883000	Operating Cash Flow: -204883000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A -216.9M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A)	Source evidence
20232023-12-31	Free cash flow	-76321000	Operating Cash Flow: -70234000 Open source Capital Expenditure: 6087000 Open source
20242024-12-31	Free cash flow	-135965000	Operating Cash Flow: -134677000 Open source Capital Expenditure: 1288000 Open source
20252025-12-31	Free cash flow	-216893000	Operating Cash Flow: -204883000 Open source Capital Expenditure: 12010000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2023-12-31	Liabilities / assets	Not reported	No source recorded
2024-12-31	Liabilities / assets	Not reported	No source recorded
2025-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2023-12-31	Current assets / current liabilities	Not reported	No source recorded
2024-12-31	Current assets / current liabilities	Not reported	No source recorded
2025-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2023 2023-01-01 – 2023-12-31	−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 80.74 million Exact value Exact value: -80736000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2023-01-01 – 2023-12-31: -80736000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Net Income Open source Share or cite Citation for Net Income · OCULAR THERAPEUTIX, INC. · 2023-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Net Income: -80736000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A&dimensions= Input fundies:NetIncome: -80736000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#3458891 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 70.23 million Exact value Exact value: -70234000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2023-01-01 – 2023-12-31: -70234000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCULAR THERAPEUTIX, INC. · 2023-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Operating Cash Flow: -70234000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A&dimensions= Input fundies:OperatingCashFlow: -70234000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2489446 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 6.09 million Exact value Exact value: 6087000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2023-01-01 – 2023-12-31: 6087000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCULAR THERAPEUTIX, INC. · 2023-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Capital Expenditure: 6087000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A&dimensions= Input fundies:CapitalExpenditure: 6087000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2495212 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 76.32 million Calculation and evidence -70234000 − 6087000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Exact free cash flow: -76321000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2023-01-01 – 2023-12-31: -70234000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 6087000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCULAR THERAPEUTIX, INC. · 2023-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Free cash flow: -76321000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -70234000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2489446 Filing: 000110465926010664 Input fundies:CapitalExpenditure: 6087000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2495212 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 193.51 million Exact value Exact value: -193506000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2024-01-01 – 2024-12-31: -193506000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Net Income Open source Share or cite Citation for Net Income · OCULAR THERAPEUTIX, INC. · 2024-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Net Income: -193506000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A&dimensions= Input fundies:NetIncome: -193506000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#3457992 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 134.68 million Exact value Exact value: -134677000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2024-01-01 – 2024-12-31: -134677000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCULAR THERAPEUTIX, INC. · 2024-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Operating Cash Flow: -134677000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A&dimensions= Input fundies:OperatingCashFlow: -134677000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2488384 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 1.29 million Exact value Exact value: 1288000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2024-01-01 – 2024-12-31: 1288000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCULAR THERAPEUTIX, INC. · 2024-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Capital Expenditure: 1288000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A&dimensions= Input fundies:CapitalExpenditure: 1288000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2494225 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 135.97 million Calculation and evidence -134677000 − 1288000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Exact free cash flow: -135965000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2024-01-01 – 2024-12-31: -134677000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1288000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCULAR THERAPEUTIX, INC. · 2024-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Free cash flow: -135965000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -134677000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2488384 Filing: 000110465926010664 Input fundies:CapitalExpenditure: 1288000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2494225 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 265.94 million Exact value Exact value: -265939000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2025-01-01 – 2025-12-31: -265939000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Net Income Open source Share or cite Citation for Net Income · OCULAR THERAPEUTIX, INC. · 2025-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Net Income: -265939000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A&dimensions= Input fundies:NetIncome: -265939000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#3457075 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 204.88 million Exact value Exact value: -204883000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2025-01-01 – 2025-12-31: -204883000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCULAR THERAPEUTIX, INC. · 2025-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Operating Cash Flow: -204883000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A&dimensions= Input fundies:OperatingCashFlow: -204883000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2487263 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 12.01 million Exact value Exact value: 12010000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2025-01-01 – 2025-12-31: 12010000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCULAR THERAPEUTIX, INC. · 2025-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Capital Expenditure: 12010000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A&dimensions= Input fundies:CapitalExpenditure: 12010000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2493146 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 216.89 million Calculation and evidence -204883000 − 12010000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Exact free cash flow: -216893000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A 2025-01-01 – 2025-12-31: -204883000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 12010000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCULAR THERAPEUTIX, INC. · 2025-12-31 OCULAR THERAPEUTIX, INC. (edgar:1393434) Free cash flow: -216893000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393434?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -204883000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2487263 Filing: 000110465926010664 Input fundies:CapitalExpenditure: 12010000 Unit_Standard_USD_PdfXOi_EoE-u479Wo9As5A (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm#2493146 Filing: 000110465926010664 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

96 filings · 5,943 latest values · 5,943 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001393434, 1393434, OCUL, edgar:1393434

Also known as I-THERAPEUTIX INC, OCULAR THERAPEUTIX, INC, OCULAR THERAPEUTIX, INC., Ocular Therapeutix, Inc, Ocular Therapeutix, Inc.

OCULAR THERAPEUTIX, INC.

Latest quarter

Revenue

Operating margin

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation